Abstract

BackgroundInterleukin (IL)-6 (mainly of tumor origin) activates glutathione (GSH) release from hepatocytes and its interorgan transport to B16-F10 melanoma metastatic foci. We studied if this capacity to overproduce IL-6 is regulated by cancer cell-independent mechanisms.MethodsMurine B16-F10 melanoma cells were cultured, transfected with red fluorescent protein, injected i.v. into syngenic C57BL/6J mice to generate lung and liver metastases, and isolated from metastatic foci using high-performance cell sorting. Stress hormones and IL-6 levels were measured by ELISA, and CRH expression in the brain by in situ hybridization. DNA binding activity of NF-κB, CREB, AP-1, and NF-IL-6 was measured using specific transcription factor assay kits. IL-6 expression was measured by RT-PCR, and silencing was achieved by transfection of anti-IL-6 small interfering RNA. GSH was determined by HPLC. Cell death analysis was distinguished using fluorescence microscopy, TUNEL labeling, and flow cytometry techniques. Statistical analyses were performed using Student’s t test.ResultsPlasma levels of stress-related hormones (adrenocorticotropin hormone, corticosterone, and noradrenaline) increased, following a circadian pattern and as compared to non-tumor controls, in mice bearing B16-F10 lung or liver metastases. Corticosterone and noradrenaline, at pathophysiological levels, increased expression and secretion of IL-6 in B16-F10 cells in vitro. Corticosterone- and noradrenaline-induced transcriptional up-regulation of IL-6 gene involves changes in the DNA binding activity of nuclear factor-κB, cAMP response element-binding protein, activator protein-1, and nuclear factor for IL-6. In vivo inoculation of B16-F10 cells transfected with anti-IL-6-siRNA, treatment with a glucocorticoid receptor blocker (RU-486) or with a β-adrenoceptor blocker (propranolol), increased hepatic GSH whereas decreased plasma IL-6 levels and metastatic growth. Corticosterone, but not NORA, also induced apoptotic cell death in metastatic cells with low GSH content.ConclusionsOur results describe an interorgan system where stress-related hormones, IL-6, and GSH coordinately regulate metastases growth.

Highlights

  • IntroductionInterleukin (IL)-6 (mainly of tumor origin) activates glutathione (GSH) release from hepatocytes and its interorgan transport to B16 melanoma F10 (B16-F10) melanoma metastatic foci

  • Interleukin (IL)-6 activates glutathione (GSH) release from hepatocytes and its interorgan transport to B16 melanoma F10 (B16-F10) melanoma metastatic foci

  • Using the highly metastatic B16 melanoma F10 (B16-F10) cell line, we reported that interleukin 6 (IL-6) facilitates GSH release from hepatocytes and its interorgan transport through the blood circulation to metastatic growing foci [4]. γ-Glutamyl transpeptidase (GGT) cleaves extracellular GSH, releasing γ-glutamyl amino acids and cysteinyl glycine, which is further cleaved by membrane-bound dipeptidases into cysteine and glycine [1,5]

Read more

Summary

Introduction

Interleukin (IL)-6 (mainly of tumor origin) activates glutathione (GSH) release from hepatocytes and its interorgan transport to B16-F10 melanoma metastatic foci We studied if this capacity to overproduce IL-6 is regulated by cancer cell-independent mechanisms. Free γglutamyl-amino acids, cysteine, and glycine entering the cell serve as GSH precursors [6] In agreement with these facts, we found that tumor GGT activity and the intertissue flow of GSH, where the liver plays a key role, regulate GSH content of B16 melanoma cells and thereby their metastatic growth [7,8]. Many cancer cells, including e.g. prostate, breast, and colon cancer or melanoma, may produce large amounts of IL-6 and express the IL-6R/gp and gp130 receptor subunits, which allow them to respond to IL-6 stimulation even in an autocrine manner [13] Whether this capacity to overproduce IL-6 is constitutive in metastatic cells and/ or regulated by cancer cell-independent mechanisms is unknown

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.